BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 11438648)

  • 1. Ligand-dependent degradation of retinoid X receptors does not require transcriptional activity or coactivator interactions.
    Osburn DL; Shao G; Seidel HM; Schulman IG
    Mol Cell Biol; 2001 Aug; 21(15):4909-18. PubMed ID: 11438648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
    Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
    J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
    Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
    EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.
    Ahuja HS; Szanto A; Nagy L; Davies PJ
    J Biol Regul Homeost Agents; 2003; 17(1):29-45. PubMed ID: 12757020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The retinoid X receptor binding to the thyroid hormone receptor: relationship with cofactor binding and transcriptional activity.
    Tagami T; Yamamoto H; Moriyama K; Sawai K; Usui T; Shimatsu A; Naruse M
    J Mol Endocrinol; 2009 May; 42(5):415-28. PubMed ID: 19211732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterodimer formation by retinoid X receptor: regulation by ligands and by the receptor's self-association properties.
    Dong D; Noy N
    Biochemistry; 1998 Jul; 37(30):10691-700. PubMed ID: 9692959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second zinc finger mutants of thyroid hormone receptor selectively preserve DNA binding and heterodimerization but eliminate transcriptional activation.
    Nagaya T; Kopp P; Kitajima K; Jameson JL; Seo H
    Biochem Biophys Res Commun; 1996 May; 222(2):524-30. PubMed ID: 8670238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corepressor interaction differentiates the permissive and non-permissive retinoid X receptor heterodimers.
    Lammi J; Perlmann T; Aarnisalo P
    Arch Biochem Biophys; 2008 Apr; 472(2):105-14. PubMed ID: 18282463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retinoid signaling is attenuated by proteasome-mediated degradation of retinoid receptors in human keratinocyte HaCaT cells.
    Boudjelal M; Voorhees JJ; Fisher GJ
    Exp Cell Res; 2002 Mar; 274(1):130-7. PubMed ID: 11855864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p300/cAMP-response-element-binding-protein ('CREB')-binding protein (CBP) modulates co-operation between myocyte enhancer factor 2A (MEF2A) and thyroid hormone receptor-retinoid X receptor.
    De Luca A; Severino A; De Paolis P; Cottone G; De Luca L; De Falco M; Porcellini A; Volpe M; Condorelli G
    Biochem J; 2003 Feb; 369(Pt 3):477-84. PubMed ID: 12371907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrate and statin synergistically increase the transcriptional activities of PPARalpha/RXRalpha and decrease the transactivation of NFkappaB.
    Inoue I; Itoh F; Aoyagi S; Tazawa S; Kusama H; Akahane M; Mastunaga T; Hayashi K; Awata T; Komoda T; Katayama S
    Biochem Biophys Res Commun; 2002 Jan; 290(1):131-9. PubMed ID: 11779144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1.
    vom Baur E; Zechel C; Heery D; Heine MJ; Garnier JM; Vivat V; Le Douarin B; Gronemeyer H; Chambon P; Losson R
    EMBO J; 1996 Jan; 15(1):110-24. PubMed ID: 8598193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid receptors interfere with the TGF-beta/Smad signaling pathway in a ligand-specific manner.
    Pendaries V; Verrecchia F; Michel S; Mauviel A
    Oncogene; 2003 Nov; 22(50):8212-20. PubMed ID: 14603262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of retinoid ligands on RIP140: molecular interaction with retinoid receptors and biological activity.
    Farooqui M; Franco PJ; Thompson J; Kagechika H; Chandraratna RA; Banaszak L; Wei LN
    Biochemistry; 2003 Feb; 42(4):971-9. PubMed ID: 12549917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Requirement of corepressor binding of thyroid hormone receptor mutants for dominant negative inhibition.
    Nagaya T; Fujieda M; Seo H
    Biochem Biophys Res Commun; 1998 Jun; 247(3):620-3. PubMed ID: 9647743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical role of glutamine 252 in the hormone-dependent transcriptional activity of the thyroid hormone beta1 nuclear receptor.
    Bhat MK; McPhie P; Cheng S
    Biochemistry; 1997 Apr; 36(14):4233-9. PubMed ID: 9100018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy.
    Germain P; Iyer J; Zechel C; Gronemeyer H
    Nature; 2002 Jan; 415(6868):187-92. PubMed ID: 11805839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A conserved retinoid X receptor (RXR) from the mollusk Biomphalaria glabrata transactivates transcription in the presence of retinoids.
    Bouton D; Escriva H; de Mendonça RL; Glineur C; Bertin B; Noël C; Robinson-Rechavi M; de Groot A; Cornette J; Laudet V; Pierce RJ
    J Mol Endocrinol; 2005 Apr; 34(2):567-82. PubMed ID: 15821117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular interaction of retinoic acid receptors with coregulators PCAF and RIP140.
    Chen Y; Hu X; Wei LN
    Mol Cell Endocrinol; 2004 Oct; 226(1-2):43-50. PubMed ID: 15489004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors.
    DiRenzo J; Söderstrom M; Kurokawa R; Ogliastro MH; Ricote M; Ingrey S; Hörlein A; Rosenfeld MG; Glass CK
    Mol Cell Biol; 1997 Apr; 17(4):2166-76. PubMed ID: 9121466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.